# IMarkHD: in Vivo Longitudinal Imaging of HD Pathology

> **NCT03434548** · — · RECRUITING · sponsor: **King's College London** · enrollment: 113 (estimated)

## Conditions studied

- Huntington Disease

## Interventions

- **RADIATION:** PET imaging
- **OTHER:** Multi-modal MRI imaging

## Key facts

- **NCT ID:** NCT03434548
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-20
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 113 (ESTIMATED)
- **Last updated:** 2025-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03434548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03434548, "IMarkHD: in Vivo Longitudinal Imaging of HD Pathology". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03434548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*